DERMAPHARM HOLDING SEDERMAPHARM HOLDING SEDERMAPHARM HOLDING SE

DERMAPHARM HOLDING SE

No trades
See on Supercharts
Market capitalization
‪1.76 B‬EUR
‪62.37 M‬EUR
‪1.14 B‬EUR
‪17.17 M‬
Beta (1Y)
0.52

About DERMAPHARM HOLDING SE

CEO
Hans-Georg Feldmeier
Headquarters
Grunwald
Founded
2017
ISIN
DE000A2GS5D8
FIGI
BBG00JRJQWW3
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DMP is 32.600 EUR — it has decreased by 1.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange DERMAPHARM HOLDING SE stocks are traded under the ticker DMP.
DERMAPHARM HOLDING SE is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
DMP stock is 2.16% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is DERMAPHARM HOLDING SE there?
DMP earnings for the last quarter are 0.27 EUR per share, whereas the estimation was 0.72 EUR resulting in a −62.50% surprise. The estimated earnings for the next quarter are 0.95 EUR per share. See more details about DERMAPHARM HOLDING SE earnings.
DERMAPHARM HOLDING SE revenue for the last quarter amounts to ‪319.10 M‬ EUR despite the estimated figure of ‪309.00 M‬ EUR. In the next quarter revenue is expected to reach ‪262.90 M‬ EUR.
Yes, you can track DERMAPHARM HOLDING SE financials in yearly and quarterly reports right on TradingView.
DMP stock has fallen by 1.51% compared to the previous week, the month change is a 3.38% fall, over the last year DERMAPHARM HOLDING SE has showed a 28.51% decrease.
DMP net income for the last quarter is ‪−2.69 M‬ EUR, while the quarter before that showed ‪24.84 M‬ EUR of net income which accounts for −110.84% change. Track more DERMAPHARM HOLDING SE financial stats to get the full picture.
Today DERMAPHARM HOLDING SE has the market capitalization of ‪1.76 B‬, it has increased by 1.37% over the last week.
Yes, DMP dividends are paid annually. The last dividend per share was 1.05 EUR. As of today, Dividend Yield (TTM)% is 3.21%. Tracking DERMAPHARM HOLDING SE dividends might help you take more informed decisions.
Like other stocks, DMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DERMAPHARM HOLDING SE stock right from TradingView charts — choose your broker and connect to your account.
DMP reached its all-time high on Jan 3, 2022 with the price of 91.950 EUR, and its all-time low was 21.200 EUR and was reached on Dec 21, 2018.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DERMAPHARM HOLDING SE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DERMAPHARM HOLDING SE stock shows the sell signal. See more of DERMAPHARM HOLDING SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DERMAPHARM HOLDING SE future price: according to them, DMP price has a max estimate of 58.00 EUR and a min estimate of 41.50 EUR. Read a more detailed DERMAPHARM HOLDING SE forecast: see what analysts think of DERMAPHARM HOLDING SE and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DERMAPHARM HOLDING SE EBITDA is ‪317.38 M‬ EUR, and current EBITDA margin is 26.86%. See more stats in DERMAPHARM HOLDING SE financial statements.